News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Nancy A. Nickman, PhD

Articles by Nancy A. Nickman, PhD

Indications for Recombinant Human Growth Hormone and Evaluation of Available Recombinant Human Growth Hormone Devices: Implications for Managed Care Organizations

ByJeffrey D. Dunn, PharmD, MBA,Nancy A. Nickman, PhD

May 8th 2012

Issues Related to Recombinant Human Growth Hormone Utilization and Optimization in a Health Plan Setting

ByNancy A. Nickman, PhD,Jeffrey D. Dunn, PharmD, MBA

May 7th 2012

Latest Updated Articles

Indications for Recombinant Human Growth Hormone and Evaluation of Available Recombinant Human Growth Hormone Devices: Implications for Managed Care Organizations
Published: May 8th 2012 | Updated:
Issues Related to Recombinant Human Growth Hormone Utilization and Optimization in a Health Plan Setting
Published: May 7th 2012 | Updated:

Trending on AJMC

Newly Unveiled ACA Premiums Show 26% Average Increase Before Subsidy Expiration

FDA Guidance to Remove One of the Largest Barriers to Biosimilar Development

Balancing Efficacy and Safety in BTKi Therapy

Immunotherapy's Evolving Role in Ovarian Cancer: Nicoletta Colombo, MD, PhD

Empagliflozin Reduces HF Risk After AMI in Patients With or Without Diabetes, CKD

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2025 MJH Life Sciences^®

All rights reserved.